In Vitro Susceptibilities of Burkholderia mallei in Comparison to Those of Other PathogenicBurkholderia spp

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1999-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.43.11.2773PMID 10543761PMCID PMC89557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral fluoroquinolones for maintenance treatment of melioidosis.

  1997cited by this paper
• In-vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei.

  1996cited by this paper
• Intracellular survival of Burkholderia pseudomallei

  1996cited by this paper
• [Sensitivity of Pseudomonas mallei to tetracyclines and their effectiveness in experimental glanders].

  1994cited by this paper
• Sensitivity of Pseudomonas mallei to tetracyclines and their effectiveness in experimental glanders

  1994cited by this paper
• [The efficacy of antibacterial preparations against Pseudomonas mallei in in-vitro and in-vivo experiments].

  1994cited by this paper
• [Effect of temperature, daunorubicin concentration and suspension hematocrit on daunorubicin binding by human erythrocytes].

  1994cited by this paper
• [Treatment of experimental glanders with combinations of sulfazine or sulfamonomethoxine with trimethoprim].

  1993cited by this paper
• Treatment of experimental glanders with combinations of sulfazine or sulfamonomethoxine with trimethoprim

  1993cited by this paper
• Sensitivity of Pseudomonas mallei to fluoroquinolones and their efficacy in experimental glanders

  1991cited by this paper
• [Sensitivity of Pseudomonas mallei to fluoroquinolones and their efficacy in experimental glanders].

  1991cited by this paper
• Melioidosis: the tip of the iceberg?

  1991cited by this paper
• Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei.

  1991cited by this paper
• Sensitivity of Pseudomonas to currently used antibacterial drugs

  1991cited by this paper
• [Sensitivity of Pseudomonas to currently used antibacterial drugs].

  1991cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically

  1990cited by this paper
• In vitro susceptibility of Pseudomonas mallei to antimicrobial agents.

  1989cited by this paper
• Halving of mortality of severe melioidosis by ceftazidime.

  1989cited by this paper
• The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment.

  1989cited by this paper
• Antimicrobial susceptibility of Pseudomonas pseudomallei.

  1987cited by this paper
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper
• Pulmonary melioidosis. Observations in thirty-nine cases.

  1975cited by this paper
• The pseudomallei group: a review.

  1971cited by this paper

• Glanders: Historical military use and potential bioterrorism concern

  2025cites this paper
• Efficacy of finafloxacin in a murine model of inhalational glanders

  2022cites this paper
• One Health surveillance approaches for melioidosis and glanders: The Malaysian perspective

  2022cites this paper
• Experimental exposure of Burkholderia pseudomallei crude culture filtrate upregulates PD-1 on T lymphocytes

  2020cites this paper
• Burkholderia, Stenotrophomonas, Ralstonia, Cupriavidus, Pandoraea, Brevundimonas, Comamonas, Delftia, and Acidovorax

  2020cites this paper
• A novel selective medium for the isolation of Burkholderia mallei from equine specimens

  2019cites this paper
• Other Pathogens

  2019cites this paper
• Aminomethyl spectinomycins: a novel antibacterial chemotype for biothreat pathogens

  2019cites this paper
• Chapter 27 MEDICAL COUNTERMEASURES

  2018cites this paper
• Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening

  2018cites this paper
• Proteomic Profiling of Burkholderia thailandensis During Host Infection Using Bio-Orthogonal Noncanonical Amino Acid Tagging (BONCAT)

  2018cites this paper
• Use of Immunohistochemistry to Demonstrate In Vivo Expression of the Burkholderia mallei Virulence Factor BpaB During Experimental Glanders

  2018cites this paper
• Chapter 8 GLANDERS

  2018cites this paper
• Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei

  2017cites this paper
• Antibiotic resistance in Burkholderia species.

  2016cites this paper
• Genetic control of survival and weight loss during pneumonic Burkholderia pseudomallei (Bp) infection

  2015cites this paper
• Glanders & Melioidosis: A Zoonosis and a Sapronosis—“Same Same, but Different”

  2015cites this paper
• Efficacy of Postexposure Therapy against Glanders in Mice

  2015cites this paper
• Meliodosis - A Lethal Trap for the Unwary

  2015cites this paper
• The Efficacy of Post-Exposure Therapy Against Glanders in Mice 1 2

  2015cites this paper
• Chapter 36 – Glanders

  2014cites this paper
• Trimethoprim/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders.

  2013cites this paper
• Glanders: an overview of infection in humans

  2013cites this paper
• Burkholderia vaccines: are we moving forward?

  2013cites this paper
• Multiple-antigen ELISA for melioidosis - a novel approach to the improved serodiagnosis of melioidosis

  2013cites this paper
• Efficacy of Post Exposure Administration of Doxycycline in a Murine Model of Inhalational Melioidosis

  2013cites this paper
• MexXY multidrug efflux system of Pseudomonas aeruginosa

  2012cites this paper
• Effectiveness of an antimicrobial treatment scheme in a confined glanders outbreak

  2012cites this paper
• The effect of glibenclamide on the pathogenesis of melioidosis

  2012cites this paper
• In vivo Bioluminescence Imaging of Burkholderia mallei Respiratory Infection and Treatment in the Mouse Model

  2011cites this paper
• Protective Antigens Against Glanders Identified by Expression Library Immunization

  2011cites this paper
• Disc diffusion based in vitro antibiotic susceptibility of recent isolates of Burkholderia mallei.

  2010cites this paper
• Antimicrobial Susceptibility of 41 Burkholderia mallei Isolates From Spontaneous Outbreaks of Equine Glanders in Punjab, Pakistan

  2010cites this paper
• Burkholderia spp. and Related Genera

  2010cites this paper
• Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis for experimental murine melioidosis.

  2010cites this paper
• Identification of Burkholderia mallei and Burkholderia pseudomallei adhesins for human respiratory epithelial cells

  2010cites this paper
• Present and future therapeutic strategies for melioidosis and glanders

  2010cites this paper
• VACCINE DEVELOPMENT AGAINST PLAGUE, GLANDERS AND MELIOIDOSIS IN THE FORMER SOVIET UNION IN COMPARSION TO THE CURRENT STATE OF GLOBAL KNOWLEDGE

  2009cites this paper
• Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin

  2009influential citation
• Chapter 21 Medical Countermeasures Introduction Bacterial and Rickettsial Diseases Anthrax Tularemia Plague Glanders and Melioidosis Brucellosis Q Fever Virology Alphaviruses Smallpox Viral Hemorrhagic Fevers

  2009cites this paper
• Implications of Antibiotic Resistance in Potential Agents of Bioterrorism

  2009cites this paper
• Experimental acute respiratory Burkholderia pseudomallei infection in BALB/c mice

  2009cites this paper
• Burkholderia mallei and Burkholderia pseudomallei

  2009cites this paper
• Melioidosis and Glanders as Possible Biological Weapons

  2009cites this paper
• High-level resistance to fluoroquinolones and cephalosporins in Burkholderia pseudomallei and closely related species.

  2008cites this paper
• Chapter 6 GLANDERS BRIDGET

  2008cites this paper
• Cases of melioidosis in a university teaching hospital in Malaysia.

  2008cites this paper
• Glanders.

  2008cites this paper
• Clinical Features and Laboratory Diagnosis of Infection with the Potential Bioterrorism Agents Burkholderia Mallei and Burkholderia Pseudomallei

  2007cites this paper
• Update on Burkholderia nomenclature and resistance

  2007cites this paper
• Category B potential bioterrorism agents: bacteria, viruses, toxins, and foodborne and waterborne pathogens.

  2006cites this paper
• Clinical guideline for diagnosis and management of melioidosis.

  2006cites this paper
• Bioterrorism and Infectious Agents

  2006cites this paper
• The Genus Burkholderia

  2006cites this paper
• Antimicrobials for Biological Warfare Agents

  2005cites this paper
• Antimicrobial Susceptibility Testing of Bacterial Agents of Bioterrorism: Strategies and Considerations

  2005cites this paper
• Glanders (Burkholderia mallei)

  2005cites this paper
• Morve, mélioïdose et bioterrorisme

  2005cites this paper
• [Glanders, melioidosis and biowarfare].

  2005cites this paper
• Rapid presumptive identification of Burkholderia pseudomallei with real-time PCR assays using fluorescent hybridization probes.

  2005cites this paper
• CARACTERIZACIÓN BIOQUIMICA Y PERFIL DE SENSIBILIDAD ANTIMICROBIANA IN VITRO DE MUESTRAS DE BURKHOLDERIA MALLEI AISLADAS DE ÉQUIDOS DE LA REGIÓN NORDESTE DE BRASIL

  2005cites this paper
• Melioidosis: Epidemiology, Pathophysiology, and Management

  2005cites this paper
• Pathogenic fungus harbours endosymbiotic bacteria for toxin production

  2005cites this paper
• Bichat guidelines for the clinical management of glanders and melioidosis and bioterrorism-related glanders and melioidosis.

  2004cites this paper
• Genome-wide comparison reveals great inter- and intraspecies variability in B. pseudomallei and B. mallei pathogens.

  2004cites this paper
• Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.

  2004cites this paper
• Patterns of large-scale genomic variation in virulent and avirulent Burkholderia species.

  2004cites this paper
• Therapeutic challenges posed by bacterial bioterrorism threats.

  2002cites this paper
• Glanders in a military research microbiologist.

  2001cites this paper
• In Vitro Antibiotic Susceptibilities ofBurkholderia mallei (Causative Agent of Glanders) Determined by Broth Microdilution and E-Test

  2001cites this paper
• Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.

  2000cites this paper